FDA recommends tightening access to hydrocodone pain-killers

FDA recommends tightening access to hydrocodone pain-killers

The FDA recommends reclassifying them more restrictively — potentially as Schedule II products, in line with opioid pain-killers such as oxycodone and morphine. Reclassifying the products would make them harder to obtain, both by addicts and by

5
Like
Save

Comments

Write a comment

*